Neeta V Gautam, MD
Family Practice · Stanford
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 17
- 3 carriers
- Office
- 1
Offices
1 location · Stanford Health Care · 3,152 clinicians in this group
Looking this up.
Hospitals listed: Stanford Health Care. That is not proof they admit you there this week.
Plans that list them
17 plans · 3 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Gautam’s office at (650) 723-4000 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
17 of 17 plans
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Silicon (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health smartHMO (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health the ONE (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| SCAN Balance (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Classic (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN MyChoice (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Strive (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| DualConnect (HMO D-SNP) | Santa Clara Family Health Plan | Listed | Sep 1, 2026 |
California Medical Board record
Licence C54881 · Current
Licensed to practise in California · since 2011 · expires 2027-04-30 · Texas A & M University College of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
State licence records
1 licence
- Texas K2813Physician License · since 1997 · expires 2025-02-28Cancelled By RequestNo board action on this licenceCheck it with the state
We check Colorado, Delaware, Florida, Illinois, Maryland, New Jersey, New York, Tennessee, Texas, Virginia, Washington, plus California above. A state that is not in this list has not been checked, which is not the same as clear.
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Stanford Health CareStanford, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of Stanford Health Care, which runs 3 hospitalsHome of Stanford Cancer Institute, a National Cancer Institute designated comprehensive cancer centrePatients rate it 4 of 5 · 83% would definitely recommend itOverall rating: 5 of 5 starsWorse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 5.31 (4.24 to 6.37) · 8,661 cases, Jul 2022 – Jun 2024Worse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 14.1 (12.7 to 15.7) · 2,191 cases, Jan 2024 – Dec 2024Better than the national rate — Postoperative respiratory failure rate: 4.08 (1.95 to 6.21) · 5,296 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.317, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.446, Oct 2024 – Sep 2025Better than the national rate — SSI - Colon Surgery: 0.241, Oct 2024 – Sep 2025Better than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 0.7 (0.6 to 0.9) · 3,348 cases, Jan 2024 – Dec 2024
See every measure and the patient survey for Stanford Health Care
Behind the star rating — Deaths: 5 better, 3 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 2 better, 5 the same, 4 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 5.31 (4.24 to 6.37) · 8,661 cases | Worse | Jul 2022 – Jun 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 14.1 (12.7 to 15.7) · 2,191 cases | Worse | Jan 2024 – Dec 2024 |
| Postoperative respiratory failure rateComplications and deaths | 4.08 (1.95 to 6.21) · 5,296 cases | Better | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.317 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.446 | Better | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.241 | Better | Oct 2024 – Sep 2025 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.7 (0.6 to 0.9) · 3,348 cases | Better | Jan 2024 – Dec 2024 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.06 (0.45 to 1.67) · 5,374 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.86 (0.72 to 1) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 166.09 (137.88 to 194.3) · 470 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.1 · 192 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6.4 · 146 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 9.7 · 253 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 6.3 · 880 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 10.3 · 935 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 8.7 · 501 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.1 · 7,730 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.13 (0 to 0.27) · 20,799 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.28 (0.14 to 0.43) · 23,182 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 0.94 (0.2 to 1.68) · 5,694 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.36 (1.54 to 3.19) · 7,846 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.2 (3.76 to 6.64) · 5,603 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.38 (0.23 to 2.53) · 2,211 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.52 (0.21 to 0.83) · 19,915 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.6 · 416 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.869 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.857 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.368 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 16.2 · 247 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.5 · 1,021 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 47.8 · 258 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -1.6 · 990 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 20.8 · 976 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.5 · 959 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.2 (4.4 to 6.2) · 2,191 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.1 · 425 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 9.6 · 158 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.6 · 183 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.7 (10.4 to 15.4) · 4,578 cases | No different | Jan 2022 – Dec 2024 |
What patients said (6,810 patients answered, 25% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 82% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 63% |
| Yes, staff "did" give patients this information | 89% |
| Yes, staff "did" give patients information about help after discharge | 89% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 79% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 79% |
| Nurses "always" treated them with courtesy and respect | 88% |
| "Always" quiet at night | 53% |
| "YES", patients would definitely recommend the hospital | 83% |
| Staff "always" explained possible side effects | 50% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
Original Medicare doctor bills
$10,695
Medicare paid this office $10,695 for 81 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Short return visit (20+ min) | 55 | $4,583 | $48 |
| Return visit (30+ min) | 24 | $1,839 | $57 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 23 | $1,561 | $68 |
| Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | 33 | $764 | $15 |
Who their Medicare patients are
81 Original Medicare patients in 2024. Average age 72 · Women 64% · Also on Medicaid 36% · Health risk score 1.28. Above the middle of the specialty; the typical family practice clinician is at 1.13.
Conditions among them: High blood pressure 65% · Diabetes 31% · Coronary heart disease 30% · Depression 26% · Cancer 19% · Chronic kidney disease 17% · COPD 14%.
The office billed $75,265, Medicare allowed $15,470 and paid $10,695; for 227 services of 12 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 81 | 227 | 72 | 1.28 | $75,265 | $10,695 |
| 2023 | 77 | 141 | 70 | 1.67 | $54,572 | $6,967 |
| 2022 | 74 | 182 | 73 | 1.27 | $63,275 | $10,323 |
| 2021 | 56 | 139 | 71 | 1.21 | $46,345 | $7,357 |
| 2020 | 58 | 121 | 70 | 1.38 | $29,727 | $5,645 |
| 2019 | 57 | 104 | 72 | 1.44 | $7,709 | $5,113 |
| 2018 | 51 | 98 | 70 | 1.49 | $7,722 | $4,541 |
| 2017 | 51 | 98 | 69 | 1.46 | $10,277 | $4,630 |
| 2016 | 59 | 132 | 70 | 1.33 | $17,538 | $6,158 |
| 2015 | 50 | 72 | 74 | 1.64 | $10,716 | $2,784 |
| 2014 | 82 | 180 | 72 | 1.50 | $25,000 | $8,167 |
| 2013 | 72 | 134 | 71 | 1.21 | $20,524 | $6,062 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 3 services
| Short return visit (20+ min) | 47 | $3,895 | $49 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 25 | $1,318 | $53 |
| Return visit (30+ min) | 17 | $956 | $50 |
2022: 4 services
| Short return visit (20+ min) | 42 | $3,979 | $52 |
| Return visit (30+ min) | 27 | $2,282 | $56 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 17 | $1,158 | $68 |
| Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | 14 | $1,148 | $82 |
2021: 3 services
| Return visit (30+ min) | 33 | $2,739 | $56 |
| Short return visit (20+ min) | 25 | $2,220 | $50 |
| Telephone medical discussion with physician, 11-20 minutes | 11 | $645 | $50 |
2020: 3 services
| Short return visit (20+ min) | 28 | $2,144 | $44 |
| Return visit (30+ min) | 23 | $1,769 | $59 |
| Telephone medical discussion with physician, 11-20 minutes | 15 | $740 | $46 |
2019: 2 services
| Short return visit (20+ min) | 37 | $2,693 | $43 |
| Return visit (30+ min) | 28 | $1,892 | $56 |
2018: 2 services
| Short return visit (20+ min) | 30 | $2,185 | $39 |
| Return visit (30+ min) | 26 | $2,115 | $66 |
2017: 2 services
| Short return visit (20+ min) | 30 | $2,342 | $42 |
| Return visit (30+ min) | 24 | $1,767 | $59 |
2016: 3 services
| Short return visit (20+ min) | 39 | $3,059 | $40 |
| Return visit (30+ min) | 20 | $1,839 | $57 |
| New patient visit (30+ min) | 13 | $814 | $63 |
2015: 2 services
| Short return visit (20+ min) | 34 | $1,652 | $37 |
| Return visit (30+ min) | 19 | $1,026 | $47 |
2014: 4 services
| Short return visit (20+ min) | 50 | $4,782 | $42 |
| Return visit (30+ min) | 15 | $1,330 | $70 |
| New patient visit (30+ min) | 20 | $1,199 | $60 |
| New patient visit (15+ min) | 14 | $581 | $42 |
2013: 4 services
| Short return visit (20+ min) | 36 | $2,416 | $41 |
| New patient visit (15+ min) | 29 | $1,088 | $38 |
| New patient visit (30+ min) | 11 | $729 | $66 |
| Short return visit | 16 | $431 | $20 |
Drugs they prescribed that Part D paid
$55,023
Pharmacies billed $55,023 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
525 generic and fewer than 11 brand-name prescriptions · $55,023 in drug cost · 15 antibiotic prescriptions.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Gabapentin | 17 | $949 | $56 |
| Duloxetine | 23 | $903 | $39 |
| Atorvastatin | 40 | $453 | $11 |
| Clopidogrel | 15 | $397 | $26 |
| Losartan | 33 | $271 | $8 |
See all 15 drugs
| Gabapentin | 17 | $949 | $56 |
| Duloxetine | 23 | $903 | $39 |
| Atorvastatin | 40 | $453 | $11 |
| Clopidogrel | 15 | $397 | $26 |
| Losartan | 33 | $271 | $8 |
| Celecoxib | 21 | $262 | $12 |
| Amlodipine Besylate | 25 | $241 | $10 |
| Metformin | 18 | $223 | $12 |
| Lisinopril | 23 | $183 | $8 |
| Alendronate | 11 | $156 | $14 |
| Fluticasone Propionate | 18 | $137 | $8 |
| Metoprolol | 11 | $106 | $10 |
| Levothyroxine | 14 | $80 | $6 |
| Carvedilol | 11 | $57 | $5 |
| Furosemide | 11 | $46 | $4 |
Year by year
| 2024 | 587 | 74 | None | None | $55,023 |
| 2023 | 527 | 71 | None | None | $50,694 |
| 2022 | 647 | 80 | None | None | $61,072 |
| 2021 | 548 | 59 | None | None | $31,114 |
| 2020 | 523 | 65 | 2% (11) | None | $59,592 |
| 2019 | 452 | 66 | 3% (14) | None | $27,675 |
| 2018 | 453 | 63 | 7% (30) | None | $33,643 |
| 2017 | 542 | 58 | 3% (17) | 12% | $31,670 |
| 2016 | 290 | 41 | 5% (13) | 13% | $13,141 |
| 2015 | 319 | 45 | 4% (12) | None | $10,819 |
| 2014 | 624 | 64 | 3% (16) | None | $22,957 |
| 2013 | 277 | 48 | None | 12% | $6,196 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 9 drugs
| Atorvastatin | 38 | $634 | $17 |
| Losartan | 30 | $629 | $21 |
| Duloxetine | 14 | $527 | $38 |
| Amlodipine Besylate | 34 | $477 | $14 |
| Clopidogrel | 17 | $399 | $23 |
| Gabapentin | 20 | $354 | $18 |
| Alendronate | 18 | $330 | $18 |
| Lisinopril | 26 | $329 | $13 |
| Metformin | 29 | $281 | $10 |
2022: 20 drugs
| Ozempic | 13 | $12,627 | $971 |
| Jardiance | 12 | $6,695 | $558 |
| Duloxetine | 27 | $1,759 | $65 |
| Diclofenac | 13 | $387 | $30 |
| Amlodipine Besylate | 44 | $371 | $8 |
| Omeprazole | 16 | $322 | $20 |
| Levothyroxine | 16 | $294 | $18 |
| Metformin | 30 | $280 | $9 |
| Lisinopril | 27 | $266 | $10 |
| Atorvastatin | 31 | $259 | $8 |
| Metoprolol | 11 | $233 | $21 |
| Losartan | 20 | $181 | $9 |
| Carvedilol | 11 | $167 | $15 |
| Tamsulosin | 13 | $165 | $13 |
| Clopidogrel | 11 | $149 | $14 |
| Hydrochlorothiazide | 15 | $139 | $9 |
| Simvastatin | 16 | $139 | $9 |
| Zolpidem | 11 | $132 | $12 |
| Gabapentin | 19 | $129 | $7 |
| Alendronate | 12 | $71 | $6 |
2021: 11 drugs
| Lidocaine | 11 | $2,753 | $250 |
| Duloxetine | 19 | $741 | $39 |
| Metformin | 32 | $437 | $14 |
| Amlodipine Besylate | 46 | $392 | $9 |
| Atorvastatin | 34 | $357 | $11 |
| Losartan | 18 | $167 | $9 |
| Simvastatin | 14 | $143 | $10 |
| Gabapentin | 19 | $121 | $6 |
| Hydrocortisone | 11 | $120 | $11 |
| Lisinopril | 22 | $109 | $5 |
| Hydrochlorothiazide | 11 | $74 | $7 |
2020: 14 drugs
| Trulicity | 13 | $15,965 | $1,228 |
| Metformin | 29 | $374 | $13 |
| Atorvastatin | 25 | $369 | $15 |
| Losartan | 26 | $368 | $14 |
| Amlodipine Besylate | 45 | $321 | $7 |
| Cyclobenzaprine | 11 | $178 | $16 |
| Simvastatin | 12 | $176 | $15 |
| Alendronate | 22 | $168 | $8 |
| Gabapentin | 12 | $131 | $11 |
| Pantoprazole | 11 | $114 | $10 |
| Zolpidem | 11 | $97 | $9 |
| Lisinopril | 17 | $93 | $5 |
| Hydrochlorothiazide | 11 | $92 | $8 |
| Metformin Hcl Er | 16 | $87 | $5 |
2019: 11 drugs
| Levothyroxine | 21 | $523 | $25 |
| Gabapentin | 25 | $369 | $15 |
| Atorvastatin | 21 | $330 | $16 |
| Metformin | 25 | $285 | $11 |
| Losartan | 22 | $221 | $10 |
| Escitalopram | 11 | $188 | $17 |
| Amlodipine Besylate | 27 | $184 | $7 |
| Simvastatin | 12 | $164 | $14 |
| Lisinopril | 20 | $159 | $8 |
| Alendronate | 15 | $147 | $10 |
| Hydrochlorothiazide | 13 | $80 | $6 |
2018: 13 drugs
| Atorvastatin | 20 | $284 | $14 |
| Losartan | 21 | $197 | $9 |
| Hydrochlorothiazide | 24 | $168 | $7 |
| Triamcinolone Acetonide | 11 | $158 | $14 |
| Amlodipine Besylate | 18 | $138 | $8 |
| Alendronate | 15 | $123 | $8 |
| Lisinopril | 13 | $112 | $9 |
| Hydrocodone-Acetaminophen | 12 | $106 | $9 |
| Metformin | 13 | $105 | $8 |
| Metformin Hcl Er | 14 | $94 | $7 |
| Escitalopram | 12 | $93 | $8 |
| Simvastatin | 13 | $68 | $5 |
| Tramadol | 16 | $34 | $2 |
2017: 16 drugs
| Levothyroxine | 17 | $474 | $28 |
| Atorvastatin | 22 | $449 | $20 |
| Valsartan | 12 | $382 | $32 |
| Losartan | 20 | $266 | $13 |
| Benazepril | 15 | $265 | $18 |
| Gabapentin | 14 | $214 | $15 |
| Amlodipine Besylate-Benazepril | 11 | $197 | $18 |
| Amlodipine Besylate | 27 | $168 | $6 |
| Lisinopril | 17 | $154 | $9 |
| Metformin | 21 | $150 | $7 |
| Alendronate | 17 | $141 | $8 |
| Metformin Hcl Er | 11 | $137 | $12 |
| Hydrochlorothiazide | 25 | $128 | $5 |
| Clopidogrel | 13 | $126 | $10 |
| Simvastatin | 20 | $122 | $6 |
| Hydrocodone-Acetaminophen | 14 | $103 | $7 |
2016: 5 drugs
| Lisinopril | 19 | $125 | $7 |
| Hydrocodone-Acetaminophen | 11 | $116 | $11 |
| Metformin | 15 | $100 | $7 |
| Amlodipine Besylate | 17 | $56 | $3 |
| Hydrochlorothiazide | 13 | $37 | $3 |
2015: 8 drugs
| Levothyroxine | 27 | $512 | $19 |
| Simvastatin | 13 | $176 | $14 |
| Pantoprazole | 12 | $156 | $13 |
| Metformin | 19 | $130 | $7 |
| Lisinopril | 12 | $120 | $10 |
| Citalopram Hbr | 18 | $78 | $4 |
| Furosemide | 13 | $74 | $6 |
| Amlodipine Besylate | 13 | $71 | $5 |
2014: 18 drugs
| Sumatriptan | 14 | $4,456 | $318 |
| Zetia | 11 | $2,171 | $197 |
| Levothyroxine | 48 | $732 | $15 |
| Mirtazapine | 12 | $405 | $34 |
| Simvastatin | 20 | $293 | $15 |
| Lisinopril | 40 | $265 | $7 |
| Atorvastatin | 21 | $235 | $11 |
| Metformin | 19 | $216 | $11 |
| Omeprazole | 19 | $132 | $7 |
| Clonazepam | 17 | $107 | $6 |
| Glipizide | 12 | $102 | $9 |
| Citalopram Hbr | 20 | $98 | $5 |
| Escitalopram | 12 | $91 | $8 |
| Pantoprazole | 12 | $85 | $7 |
| Trazodone | 14 | $78 | $6 |
| Amlodipine Besylate | 14 | $72 | $5 |
| Diazepam | 14 | $65 | $5 |
| Furosemide | 18 | $58 | $3 |
2013: 4 drugs
| Gemfibrozil | 11 | $212 | $19 |
| Metformin | 21 | $179 | $9 |
| Lisinopril | 26 | $164 | $6 |
| Simvastatin | 13 | $110 | $8 |
Professional record
- NPI
- 1265650964
- Licence
- CA C54881, TX K2813California C54881: Current · expires 2027-04-30Texas K2813: Cancelled By Request
- Trained
- Texas A & M University System, Hsc, College of Medicine, 1996
- Group
- Stanford Health Care
- Video visits
- Lists video visits
- Gender
- Female
More record details
- Sole proprietor
- No
- Medicaid ID
- TX 105373805
- Taxonomy
- Family medicine (207Q00000X)
- Mailing address
- 300 Pasteur Dr, Stanford, CA, 94305
- NPI first listed
- 2007-04-20
- NPI last updated
- 2024-04-29
- NPI record certified
- 2024-04-29
This is when the NPI record was last certified, not a medical board exam.